Salk research focuses on the development of compounds that may protect against the diseases of aging, such as Alzheimer’s
Old age is the greatest risk factor for many diseases, including Alzheimer’s disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New Salk research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.
“The argument for geroprotectors is that if one can extend the lifespan of model organisms, such as mice, and translate this effect to humans, then you should be able to slow down the appearance of many diseases that are associated with aging, such as Alzheimer’s, Parkinson’s, cancer and overall frailty,” says first author Dave Schubert, Salk professor and head of Salk’s Cellular Neurobiology Laboratory.
The study, which appeared in the journal Trends in Pharmacological Sciences, on November 13, 2018, was conducted in collaboration with Salk Senior Staff Scientist Pamela Maher, whose lab is in the Cellular Neurobiology department and who is the study’s senior author.
The team started with two chemicals found in plants that have demonstrated medicinal properties: fisetin, a natural product derived from fruits and vegetables, and curcumin, from the curry spice turmeric. From these, the team synthesized three AD drug candidates based upon their ability to protect neurons from multiple toxicities associated with the aging brain. The lab showed that these three synthetic candidates (known as CMS121, CAD31 and J147), as well as fisetin and curcumin, reduced the molecular markers of aging, as well as dementia, and extended the median lifespan of mice or flies.
Importantly, the group demonstrated that the molecular pathways engaged by these AD drug candidates are the same as two other well-researched synthetic compounds that are known to extend the lifespan of many animals. For this reason, and based on the results of their previous studies, the team says fisetin, curcumin and the three AD drug candidates all meet the definition of being geroneuroprotectors.
The group is now focusing on getting two GNPs into human clinical trials. The fisetin derivative, CMS121, is currently in the animal toxicology studies required for FDA approval to start clinical trials. The curcumin derivative, J147, is under FDA review for allowance to start clinical trials for AD early next year. The group plans to incorporate biochemical markers for aging into the clinical trials to assay for potential geroprotective effects.
“Since we found that the natural products curcumin and fisetin are also GNPs and commercially available as supplements, they could provide some therapeutic benefits right now,” says Maher.
Other studies in the lab are determining whether these compounds have effects on organs outside of the brain. “If these drugs have benefits for other body systems, such as maintaining kidney function and overall muscle health, they could be used in additional ways to treat or prevent the diseases of aging,” Schubert says.
The investigators say that the discovery of these AD drug candidates validates the drug discovery model they have developed as a plausible method for identifying additional GNP compounds that will help promote healthy aging. This could greatly accelerate the pipeline for drugs to treat the diseases of aging for which there are currently no cures.
The Latest on: Anti-aging
No news articles
via Google News
The Latest on: Anti-aging
- Amazon Shoppers Say This Anti-Aging Cream Works Like 'Magic' on Mature Skin, and It's Currently 50% Offon December 2, 2020 at 4:00 pm
One of the recent ingredients to make waves in the skincare world is snail slime, better known as snail mucin. A trusted additive in many Korean beauty products, it’s hailed as a solution for ...
- Nordstrom Reviewers Say This Anti-Aging Serum Works in Days — and It's $30 Offon December 2, 2020 at 3:00 pm
New beauty products drop like leaves every day. Some bring glamorous, super effective new formulas to our medicine cabinets, but it’s a truly special serum that doesn’t just earn a place in ...
- ‘Milestone’ Anti-Aging Treatment Restores Sight in Miceon December 2, 2020 at 7:57 am
Scientists said Wednesday they have restored sight in mice using a “milestone” treatment that returns cells to a more youthful state and could one day help treat glaucoma and other ...
- Anti-aging Mystery Nears Conclusion As Scientists Identify Gene Responsible For Waning Cellson December 1, 2020 at 5:20 am
A team of scientists identified the molecular mechanism that causes different body organs to age. The discovery is an important step in pushing regenerative medicine forward.
- Anti Aging Market Research With Size, Growth, Manufacturers, Segments And 2026 Forecasts Researchon December 1, 2020 at 3:54 am
The anti aging market is segmented on the lines of its age geographic, product, services, devices and regional. Based on ...
- Shoppers Say This Anti-Aging Serum Makes Them Look 10 Years Younger, and It’s 30% Offon November 30, 2020 at 4:00 pm
Yes, there are those that prove their worth right out of the gate, but more often than not, products don’t make a life-changing difference — and when they do, it’s after months of steady use. So when ...
- This Anti-Aging Cream Fades Acne Scars and Wrinkles—and It’s Nearly 50% Off for Cyber Mondayon November 30, 2020 at 12:15 pm
My wrinkles are less noticeable. My complexion is clearer and brighter. The age spots seem to be disappearing.” ...
- Anti-aging skin treatment receives Health Ministry, FDA, CE approvalon November 29, 2020 at 4:55 am
With the approval by the Medical Equipment Division of the Health Ministry, the technology has received the go ahead from both the CE certification board as well as the US FDA.
- Anti-Aging Products and Therapies Market Size to Surpass US$ 16630 million By 2025on November 26, 2020 at 3:53 am
Aging Products and Therapies Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Anti-Aging Products and Therapies Market ...
via Bing News